Vudalimab Biosimilar - Anti-CTLA4; PDCD1 mAb - Research Grade
Product Specifications
Synonyms
Vudalimab, ANTI-PD-1/ANTI-CTLA-4 XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI- (HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152) ) AND ANTI- (HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279) ), MONOCLONAL ANTIBODY, BISPECIFIC, CTLA4; PDCD1, anti-CTLA4; PDCD1
UniProt
Q15116 & P16410
Expression System
XtenCHO
Clonality
Monoclonal
Type
Biosimilars
Buffer
PBS buffer PH7.5
Shipping Conditions
Blue Ice (+4°C)
Storage Conditions
4°C for short term (1 week), store at -20°C to -80°C for long term (1 year) ; Avoid repeated freeze-thaw cycles
Brand
ProteoGenix
Isotype
Bispecific , IgG1, Kappa; Kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog